Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 14, 2008

TGen to Assess febit’s DNA Capture Method in Next-Generation Sequencing Efforts

  • Translational Genomics Research Institute (TGen) will febit's HybSelect™ in next-generation sequencing equipment. The partnership thus provides TGen scientists premarket access to this technology, which is a method for capturing DNA.

    “We will obtain important data from TGen that will help us as we prepare for the official introduction of HybSelect in early 2009,” says Cord F. Staehler, president of febit.

    HybSelect enables selective DNA capture and elution, an efficient method to preselect sequences for next-generation sequencers, the companies report. It is based on febit's Geniom Technology and uses arrays within microfluidic biochips for the selection process of targeted DNA. Geniom biochips are programmable and can contain any desired set of capture probes.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »